Indie Asset Partners, LLC Emergent Bio Solutions Inc. Transaction History

Indie Asset Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$50.07 - $66.05 $165,231 - $217,965	-3,300 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $12,737 - $18,103	-225 Reduced 6.38%	3,300 $208,000
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $17,246 - $25,038	200 Added 6.02%	3,525 $328,000
Q4 2020 Feb 09, 2021	BUY	$79.17 - $111.47 $263,240 - $370,637	3,325 New	3,325 $298,000

136

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $373M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indie Asset Partners, LLC with notifications on news.